Sangamo Therapeutics Inc. Insider Trading

SGMO

Last 12 months

Insiders sold 107K and bought nothing on the open market.

None of the selling was scheduled in advance under a 10b5-1 plan. Svp-chief Development Officer Nathalie Dubois-Stringfellow sold 90K on Apr 21, 51% of their stake, outside a plan. The last open-market buy by an executive or director was in Jun 2022.

Net open-market

−107K

0 buys · 2 sales

Under a 10b5-1 plan

of the value sold

Insiders who bought / sold

0 / 2

executives and directors

Last open-market buy

Jun 2022

Jun 3, 2022

Get an email when SGMO's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Apr 22	Gregory D Davis Head of Research & Technology	SoldNo plan	69,827	$0.25	17K	38%	Form 4
Apr 21	Nathalie Dubois-Stringfellow Svp-chief Development Officer	SoldNo plan	345,942	$0.26	90K	51%	Form 4

Apr 22No plan
Gregory D Davis
Head of Research & Technology · sold 69,827 at $0.25
17K
38% of stake
Apr 21No plan
Nathalie Dubois-Stringfellow
Svp-chief Development Officer · sold 345,942 at $0.26
90K
51% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch SGMO, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Biological Products, (No Diagnostic Substances) · Pick stocks to compare with SGMO

CompareIntrinsic value

VYGRVoyager Therapeutics Inc.

$1.87+2.19%10

CCCCC4 Therapeutics Inc.

$3.12-2.80%33

SCLXScilex Holding Company

$1.83-1.08%0

GLUEMonte Rosa Therapeutics, Inc.

$10.82+3.94%10

PTHSPelthos Therapeutics Inc.

$10.15-5.84%0

MGXMetagenomi, Inc.

$0.79+3.95%10

DTILPrecision Biosciences Inc.

$7.89+13.20%48

STROSutro Biopharma, Inc.

$9.94+4.52%10

Spot a number that looks wrong? Check it in SGMO's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing SGMO

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.